Drug
BI-764198 clinical trials
Also written BI 764198.
- studies test it
- 11
- open now
- 2
- in phase 3
- 1
- first study started
- 2019
Keep track of what changes. Save the BI-764198 studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
11 studies that test it; most in 2026 (4)
| Year | Studies |
|---|---|
| 2019 | 3 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 1 |
| 2026 | 4 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 7
- Phase 2
- 3
- Phase 3
- 1
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 11 · Other 0
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses BI-764198 is read from its arms, and is right about nine times in ten.
Testing it · 11
- A Study to Find Out if BI 764198 Helps Adults and Adolescents With a Kidney Condition Called Focal Segmental Glomerulosclerosis (FSGS)RecruitingPhase 3Boehringer IngelheimNCT07220083Written as BI 764198
- PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney DiseaseRecruitingPhase 2Boehringer IngelheimNCT07355296Written as BI 764198
- A Study in People With Normal Kidney Function and People With Reduced Kidney Function to Test How BI 764198 is Processed in the BodyCompletedPhase 1Boehringer IngelheimNCT04176536Written as BI 764198
- A Study in Healthy Men Tests How Different Doses of BI 764198 Are Taken up in the Body and How Well They Are Tolerated.CompletedPhase 1Boehringer IngelheimNCT03854552Written as BI 764198
- A Study in Healthy People to Test Whether BI 764198 Influences the Amount of Metformin in the BodyCompletedPhase 1Boehringer IngelheimNCT07368569Written as BI 764198
- A Study in Healthy Men to Test How Itraconazole Influences the Amount of BI 764198 in the BloodCompletedPhase 1Boehringer IngelheimNCT07308652Written as BI 764198
- A Study in Healthy Men to Test How BI 764198 is Processed in the BodyCompletedPhase 1Boehringer IngelheimNCT05863130Written as BI 764198 (C-14) (approach 1)
- A Study to Test BI 764198 in People With a Type of Kidney Disease Called Focal Segmental GlomerulosclerosisCompletedPhase 2Boehringer IngelheimNCT05213624Written as BI 764198
- ACTION ON COVID-19: A Study to Test Whether BI 764198 Helps Lung Health of People Hospitalised With COVID-19TerminatedPhase 2Boehringer IngelheimNCT04604184Written as BI 764198
- A Study in Healthy Japanese Men to Test How Well Different Doses of BI 764198 Are ToleratedCompletedPhase 1Boehringer IngelheimNCT04665700Written as BI 764198
- A Study to Test How Well Healthy Men Tolerate Different Doses of BI 764198CompletedPhase 1Boehringer IngelheimNCT04102462Written as BI 764198